FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD) EP News Bureau Oct 25, 2021 Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an…
